{
    "name": "Clomipramine",
    "genericName": "Anafranil",
    "tags": [
        "TCA",
        "ocd",
        "depression",
        "anxiety"
    ],
    "dosing": {
        "adult_acute": "25-250 mg/day",
        "adult_maintenance": "100-150 mg/day",
        "notes": "Take at bedtime to minimize sedation. Titrate slowly to reduce side effects.",
        "canadian_clinical": {
            "starting_dose": "25 mg/day at bedtime",
            "titration_schedule": "Increase by 25 mg every 3-5 days as tolerated.",
            "inpatient_strategy": "Start 25 mg nocte. Titrate to 100-150 mg over 1-2 weeks. Target 150-250 mg for OCD.",
            "outpatient_strategy": "Start 25 mg nocte x 1 week, then 50 mg. Review in 4 weeks. Target therapeutic dose over 4-6 weeks.",
            "max_dose_evidence": "250 mg/day (OCD)",
            "max_dose_practice": "300 mg/day (inpatient monitoring required above 250 mg)."
        }
    },
    "cautions": {
        "renal": "Use with caution; limited data. Start low.",
        "hepatic": "Avoid in severe hepatic impairment. Reduce dose in mild-moderate impairment.",
        "pregnancy": "Avoid if possible; neonatal withdrawal reported. Use only if benefit outweighs risk."
    },
    "warnings": [
        "QTc prolongation â€” ECG recommended before and during treatment",
        "Seizure risk (dose-dependent, especially >250 mg/day)",
        "Anticholinergic effects: dry mouth, constipation, urinary retention, blurred vision",
        "Orthostatic hypotension",
        "Sedation",
        "Serotonin Syndrome risk (avoid combining with MAOIs)",
        "Black box: Increased suicidal ideation in children and adolescents"
    ],
    "citations": [
        "CANMAT Depression 2016",
        "APA OCD Practice Guidelines",
        "Maudsley Prescribing Guidelines 14th ed"
    ]
}
